Management of myocardial infarction with ST-segment elevation in district hospitals without catheterisation laboratory - Acute Coronary Syndromes Registry of Małopolska 2002-2003

Kardiologia Polska

Volumn 64, Issue 10, 2006, Pages 1053-1060

  Dudek, Dariusz ^a,c   Siudak, Zbigniew ^a   Kuta, Marcin ^b   Dziewierz, Artur ^a   Mielecki, Waldemar ^a   Rakowski, Tomasz ^a   Giszterowicz, Dawid ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b E Szczeklik Hospital   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Acute coronary syndrome; Acute myocardial infarction with ST segment elevation; Fibrinolysis; Percutaneous coronary intervention; Registry

Indexed keywords

FIBRINOLYTIC AGENT; PROTEIN INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CATHETERIZATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; FIBRINOLYSIS; HEALTH CARE FACILITY; HEART INFARCTION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT REFERRAL; PUBLIC HOSPITAL; REGISTER; REPERFUSION; RISK FACTOR; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREATMENT CONTRAINDICATION;

EID: 33750967936     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28-66.
2. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671-719.
3. Grines C, Patel A, Zijlstra F, et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003; 145: 47-57.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
5. Bednar F, Widimsky P, Krupicka J, et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol 2003; 19: 1133-7.
6. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733-42.
7. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359: 373-7.
8. Siudak Z, Dudek D, Kuta M, et al. Codzienna praktyka kliniczna w ostrych zespołach wieńcowych bez uniesienia odcinka ST w szpitalach rejonowych - rejestr w Małopolsce. Folia Cardiol 2005; 12: 21-31.
9. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
10. Yan AT, Tan M, Fitchett D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2004; 94: 25-9.
11. Zeymer U, Senges J. Why do we need prospective registries in patients with acute myocardial infarction? Eur Heart J 2003; 24: 1611-2.
12. Dudek D, Siudak Z, Kuta M, et al. Charakterystyka kliniczna oraz leczenie u pacjentów z ostrymi zespołami wieńcowymi w szpitalach bez pracowni kardiologii inwazyjnej. Małopolski Rejestr Ostrych Zespołów Wieńcowych 2002-2003. Postȩpy w Kardiologii Interwencyjnej 2005; 1, 2: 97-106.
13. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23: 1190-201.
14. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-63.
15. Grace Investigators. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001; 141: 190-9.
16. Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000; 86: 4M-9M.
17. Fox KA, Cokkinos DV, Deckers J, et al. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000; 21: 1440-9.
18. Fox KA, Goodman SG, Anderson FA Jr, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1414-24.
19. Schomig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005; 293: 2865-72.
20. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006; 354: 1477-88.
21. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47.
22. Gyongyosi M, Domanovits H, Benzer W, et al. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multicentre randomized ReoPro-BRIDGING Study. Eur Heart J 2004; 25: 2125-33.
23. Goedicke J, Flather MD, Arntz H-R, et al. Upstream administration of abciximab prior to primary angioplasty improves epicardial patency and myocardial tissue perfusion - results from a meta-analysis of 603 cases. J Am Coll Cardiol 2005; 45: 250A (abstract).
24. Zorman S, Zorman D, Noc M. Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty. Am J Cardiol 2002; 90: 533-6.
25. Dudek D, Żmudka K, Kałuża GL, et al. Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals. Am J Cardiol 2003; 91: 227-9.
26. Dudek D, Dziewierz A, Rakowski T, et al. Angiographic and clinical outcome after percutaneous coronary interventions following combined fibrinolytic therapy in acute myocardial infarction. Kardiol Pol 2006; 64: 239-47.
27. Di Mario C, Bolognese L, Maillard L, et al. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). Am Heart J 2004; 148: 378-85.